1. Short title This Act may be cited as the Access to Breast Cancer Diagnosis Act of 2023 . 2. Requiring diagnostic and supplemental breast examinations to be covered with no cost-sharing requirements (a) In general Subpart II of part A of title XXVII of the Public Health Service Act ( 42 U.S.C. 300gg–11 et seq. ) is amended by adding at the end the following new section: 2730. Diagnostic and supplemental breast examinations (a) In general In the case of a group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to diagnostic and supplemental breast examinations furnished to an individual enrolled under such plan or such coverage, such plan or coverage shall not impose any cost-sharing requirements for these benefits. (b) Construction Nothing in this section shall be construed— (1) to prohibit a group health plan or health insurance issuer from requiring timely prior authorization or imposing other appropriate utilization controls in approving coverage for any diagnostic and supplemental breast examination; or (2) to supersede a State law that provides greater protections with respect to the coverage of diagnostic and supplemental breast examinations than is provided under this section. (c) Definitions In this section: (1) Cost-sharing requirements The term cost-sharing requirements means a deductible, coinsurance, copayment, and any maximum limitation on the application of such a deductible, coinsurance, copayment or similar out-of-pocket expense. (2) Diagnostic breast examination The term diagnostic breast examination means a medically necessary and appropriate (in accordance with National Comprehensive Cancer Network Guidelines) examination of the breast (including such an examination using diagnostic mammography, breast magnetic resonance imaging, or breast ultrasound) that is— (A) used to evaluate an abnormality seen or suspected from a screening examination for breast cancer